welcome to oneFAPvoice
- a positively charged Familial Adenomatous Polyposis community.- join today!
- login
Tucson drug startup launches gastric-cancer trial
Tucson-based drug startup Cancer Prevention Pharmaceuticals Inc. has announced the launch of a Phase 2 clinical trial at Vanderbilt University Medical Center to test the company’s flagship drug candidate for preventing gastric cancer.
The drug, CPP-1X, will be studied in patients with precancerous gastric lesions who are at high risk for gastric cancer, the company said Monday.
The trial is funded by the National Cancer Institute and run in collaboration with gastroenterologists Dr. Keith T. Wilson and Dr. Douglas R. Morgan of the Vanderbilt University School of Medicine and the Vanderbilt-Ingram Cancer Center.
expertly curated content related to this topic
- Non-Invasive Prediction of Colorectal NeoplasiaHypothesis:The Adnab-9 antigen is a ...
- J-Pouch Diet Blog Post from GUT-LESSWhile I cannot speak for everyone who li...
- Rectal and Pouch Recurrences After Surgical Treatment for Familial Adenomatous PolyposisBACKGROUND : Familial adenomatous polypo...
- Meta-Analysis of Observational Studies of Ileorectal Versus Ileal Pouch-Anal Anastomosis for Familial Adenomatous Po...BACKGROUND : Surgery for familial adenom...
- Colorectal Polyps in ChildhoodPURPOSE OF REVIEW: Colorectal polyps ar...
- Papa’s Got A Brand New Bag!I miss you, I need you, and I’m scared...
- Anorectal Functional Outcome After Repeated Transanal Endoscopic MicrosurgeryAIM : To evaluate the status of anorecta...